Go to deals
Private Equity | Healthcare | Industrial Machinery & Components

KKR to invest in Precipart Group Ltd.

Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.

Precipart, founded in 1950 by the Laubscher family with roots in Swiss engineering and manufacturing, is a leading contract development and manufacturing organization of highly engineered precision components and assemblies, primarily for the medical device industry as well as the aerospace and industrial markets. Precipart, through its mission to Engineer Possible, is a comprehensive solution provider supporting its customers from the concept phase to serial production and in managing their growing supply chain complexity. Major product offerings include precision machining, micro mechanical components, assemblies, gear systems, motion solutions, technical ceramics and advanced 3D printing.

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people and supporting growth in its portfolio companies and communities. KKR is investing in Precipart through its Health Care Strategic Growth Fund, a fund dedicated to investing in high-growth healthcare-related companies to which KKR can be a unique strategic partner in helping reach scale.

The Laubscher family remains highly committed to Precipart and is retaining a significant minority ownership stake in the company.

Oaklins’ team in Switzerland acted as the exclusive sell-side advisor to the shareholders of Precipart in the transaction. Oaklins TM Capital approached potential investors in the US market and supported the transaction at its early stages.

Parties
“My team, my family and I are thrilled to form this strategic partnership with KKR, who are the right partners to help take Precipart to the next level. The Oaklins team has been instrumental in concluding the transaction with our partner of choice. We have appreciated their high level of commitment, professionalism and guidance through the whole process.”

Oliver Laubscher

Member of the Board and CEO, Precipart Group Ltd.

Talk to the deal team

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland

Jens Rutten

Partner
Zurich, Switzerland
Oaklins Switzerland

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

John Dean

Associate Director
Atlanta, United States
Oaklins TM Capital

Christoph Walker

Associate Director
Zurich, Switzerland
Oaklins Switzerland

Related deals

PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas
Private Equity | Construction & Engineering Services

PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas

Nazca Capital and the company founders have sold PBV Investment Holding Europe-America, S.L. (IDP Group) to Bureau Veritas. This strategic acquisition will allow Bureau Veritas to expand its leadership in building and infrastructure solutions and meet sustainability challenges through IDP’s digital portfolio assets.

Learn more
Energy Solutions UK Ltd. has acquired Oceanic Systems (UK) Ltd.
Energy | Industrial Machinery & Components

Energy Solutions UK Ltd. has acquired Oceanic Systems (UK) Ltd.

Energy Solutions UK Ltd., a marine electrical systems supplier, has completed the acquisition of marine monitoring and control systems manufacturer, Oceanic Systems (UK) Ltd. The acquisition is designed to expand Energy Solutions’ marine technology offerings, particularly supporting their growth in marine hybrid propulsion systems.

Learn more
HD Clinical Ltd. has been acquired by NEXUS AG
Healthcare | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Learn more